Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily F Dunn

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Advances in Radiation Oncology|March 28, 2023
Effect of COVID-19 on Gynecologic Oncology Care: A Survey of Practicing Gynecologic Radiation Oncologists in the United StatesJeffrey V Brower, Sylvia S Rhodes, Jill S Remick, et al.
Molecular Cancer Therapeutics|March 18, 2014
Nuclear epidermal growth factor receptor is a functional molecular target in triple-negative breast cancerToni M Brand, Mari Iida, Emily F Dunn, et al.
Brachytherapy|May 4, 2020
COVID-19 impact on timing of brachytherapy treatment and strategies for risk mitigationVonetta M Williams, Jenna M Kahn, Matthew M Harkenrider, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Advances in Radiation Oncology|March 28, 2023
Effect of COVID-19 on Gynecologic Oncology Care: A Survey of Practicing Gynecologic Radiation Oncologists in the United StatesJeffrey V Brower, Sylvia S Rhodes, Jill S Remick, et al.
Molecular Cancer Therapeutics|March 18, 2014
Nuclear epidermal growth factor receptor is a functional molecular target in triple-negative breast cancerToni M Brand, Mari Iida, Emily F Dunn, et al.
Brachytherapy|May 4, 2020
COVID-19 impact on timing of brachytherapy treatment and strategies for risk mitigationVonetta M Williams, Jenna M Kahn, Matthew M Harkenrider, et al.
Pageof 2